These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3293575)

  • 1. [Monoclonal antibodies--new probes for diagnosis and therapy. Their use as an example of the micrometastasizing of solid tumors].
    Schlimok G; Funke I; Bock B; Schweiberer B; Riethmüller G
    Arzneimittelforschung; 1988 Mar; 38(3A):435-7. PubMed ID: 3293575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection, characterization and tumorigenicity of disseminated tumor cells in human bone marrow.
    Schlimok G; Riethmüller G
    Semin Cancer Biol; 1990 Jun; 1(3):207-15. PubMed ID: 2103496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies.
    Schlimok G; Funke I; Holzmann B; Göttlinger G; Schmidt G; Häuser H; Swierkot S; Warnecke HH; Schneider B; Koprowski H; Riethmüller G
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8672-6. PubMed ID: 2446326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous detection in the bone marrow of mammary cancer metastatic cells and of their labelling index as respective markers of the residual minimum submacroscopic disease and its proliferative condition (preliminary results).
    Ginsbourg M; Musset M; Misset JL; Genty O; Mathé G
    Biomed Pharmacother; 1986; 40(10):386-8. PubMed ID: 3555638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of mammary metastatic cells in the bone marrow as a marker of a minimal residual disease and of their proliferative index as a factor of prognosis--an immunocytologic study with monoclonal antibodies.
    Ginsbourg M; Musset M; Misset JL; Genty O; Mathé G
    Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):51-4. PubMed ID: 2743531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer.
    Pantel K; Izbicki JR; Angstwurm M; Braun S; Passlick B; Karg O; Thetter O; Riethmüller G
    Cancer Res; 1993 Mar; 53(5):1027-31. PubMed ID: 7679945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rating of isolated disseminated tumor cells in bone marrow in comparison with other factors of prognosis in breast carcinoma.
    Leinung S; Würl P; Schönfelder A; Weiss CL; Röder I; Schönfelder M
    Int J Surg Investig; 2000; 2(3):193-202. PubMed ID: 12678519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contribution of immunohistochemical technics to the study of malignant infiltration of bone marrow].
    Delsol G; Al Saati T; Faure PH; Caverivière P; Chittal S; Rigal-Huguet F; Robert A; Laurent G; Pris J
    Pathol Biol (Paris); 1988 Jan; 36(1):11-6. PubMed ID: 3283666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC-class I antigen expression on micrometastases in bone marrow of patients with head and neck squamous cell cancer.
    Andratschke M; Pauli C; Stein M; Chaubal S; Wollenberg B
    Anticancer Res; 2003; 23(2B):1467-71. PubMed ID: 12820411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators.
    Hofmann T; Riesenberg R; Buchner A; Zimmermann W; Hofstetter A; Oberneder R
    J Urol; 2003 Apr; 169(4):1303-7. PubMed ID: 12629348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow.
    Pantel K; Schlimok G; Angstwurm M; Weckermann D; Schmaus W; Gath H; Passlick B; Izbicki JR; Riethmüller G
    J Hematother; 1994; 3(3):165-73. PubMed ID: 7530132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and prognostic value of cytokeratin positive tumor cells in bone marrow of patients with renal cell carcinoma.
    Buchner A; Riesenberg R; Kotter I; Crispin A; Hofstetter A; Oberneder R
    J Urol; 2003 Nov; 170(5):1747-51. PubMed ID: 14532768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
    Johnston WW
    Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivity of a monoclonal antibody with tissues and tumors from the human breast. Immunohistochemical localization of a new antigen and clinicopathologic correlations.
    Mariani-Costantini R; Barbanti P; Colnaghi MI; Ménard S; Clemente C; Rilke F
    Am J Pathol; 1984 Apr; 115(1):47-56. PubMed ID: 6711680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The usefulness of monoclonal antibodies in the diagnosis of lung carcinoma].
    De Blasio F; Prisco C; Pezza A
    Arch Monaldi Mal Torace; 1990; 45(3):195-202. PubMed ID: 1669273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated tumor cells in the bone marrow: value of a new diagnostic method in the TNM-staging of solid tumors.
    Werner M; Nasarek A; Georgii A
    Gen Diagn Pathol; 1996 Jun; 142(1):1-6. PubMed ID: 8793480
    [No Abstract]   [Full Text] [Related]  

  • 18. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
    Epstein AL; Marder RJ; Winter JN; Fox RI
    J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of disseminated lung cancer cells in lymph nodes by monoclonal antibodies: impact on staging and prognosis.
    Passlick B
    Ann Ital Chir; 1999; 70(6):839-40. PubMed ID: 10804658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
    Brenner BG; Jothy S; Shuster J; Fuks A
    Cancer Res; 1982 Aug; 42(8):3187-92. PubMed ID: 7046919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.